Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Hailing Traditional Chinese Medicine Pharmaceutical Technology Research is a specialized research and development institute based in Nanjing, China, serving as a core R&D subsidiary of the Yangtze River Pharmaceutical Group. The institute focuses on the modernization of Traditional Chinese Medicine (TCM), specializing in advanced extraction techniques, formulation development, and the standardization of herbal products. It plays a critical role in bridging traditional herbal knowledge with modern pharmaceutical manufacturing standards, conducting extensive research into the quality control and clinical efficacy of botanical drugs. The organization supports the broader group's portfolio by advancing both innovative TCM candidates and chemical drug formulations through various stages of development. Its work has contributed to several high-profile commercial products widely used in the Chinese healthcare market for respiratory and inflammatory conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing Hailing Traditional Chinese Medicine Pharmaceutical Technology Research.